LFC Comments; Thanks to a young Concord lobbyist for this article. I want the treatment that President Trump got for his case of CoVid-19.]
What is remdesivir?
Remdesivir is an antiviral medication that is given by intravenous (IV) infusion in the hospital. It previously showed some effect against viruses such as SARS, MERS, and Ebola in cell and animal models.
In a more recent in vitro study (studies done in a petri dish or test tube rather than in animals or humans), remdesivir prevented human cells from being infected with SARS-CoV-2 (the virus that causes COVID-19).
When was remdesivir approved to treat COVID-19?
On October 22, 2020, the FDA approved remdesivir for patients 12 years and older and weighing at least 40 kg (88 lbs) to treat COVID-19 requiring hospitalization. It works by blocking an enzyme that is needed for the SARS-CoV-2 viruses to replicate.
Prior to the FDA approval, remdesivir was available by joining a clinical trial, via a compassionate use program, or under an Emergency Use Authorization (EUA). The intent of the EUA was to make it easier for doctors to get remdesivir for hospitalized patients, particularly those who did not qualify for a clinical trial. Now that remdesivir is approved for certain patients, the EUA only applies to children under 12 or weighing less than 40 kg (88 lbs).Don’t miss out on savings!
Hydroxychloroquine and chloroquine
Hydroxychloroquine and chloroquine are two medications that have been used for many decades to treat malaria and autoimmune conditions like rheumatoid arthritis and lupus. A few small studies initially suggested that they may also be helpful for treating hospitalized patients with mild cases of COVID-19, though the current consensus from national health institutions (such as the FDA) is that hydroxychloroquine and chloroquine do not work for preventing or treating COVID-19. Clinical guidelines from the NIH recommend against their use for COVID-19. More detailed information about hydroxychloroquine and chloroquine studies can be found here.